Table 1 Characteristics of patients and His.
Characteristics | Total patients | Patients’ reported intolerable side effects |
|---|---|---|
Patients | ||
Gender† | ||
Male | 318 (25.2) | 7 (26.9) |
Female | 942 (74.8) | 19 (73.1) |
Gestational age† | ||
Term born (≥37 w) | 1034 (82.1) | 18 (69.2) |
Born prematurely (<37 w) | 226 (17.9) | 8 (30.8) |
Age when starting propranolol treatment (d)‡ | 96 (68–155) | 60 (49–77) |
Body weight when starting propranolol treatment (kg)‡ | 6.4 (5.9–6.8) | 5.7 (5.2–6.1) |
Duration of propranolol treatment (d)‡ | 337 (249–423) | 50 (18–85) |
IHs | ||
Location†# | ||
Head, face and neck | 668 (53.0) | 14 (53.8) |
Extremity | 211 (16.7) | 4 (15.4) |
Trunk | 326 (25.9) | 7 (26.9) |
Perineal | 45 (3.6) | 1 (3.8) |
Internal | 10 (0.8) | 0 (0) |
Morphologic subtype† | ||
Localized | 882 (70.0) | 18 (69.2) |
Segmental | 125 (9.9) | 3 (11.5) |
Indeterminate | 201 (16.0) | 4 (15.4) |
Multifocal | 52 (4.1) | 1 (3.8) |
Description†# | ||
Superficial | 190 (15.1) | 4 (15.4) |
Mixed | 943 (74.8) | 20 (76.9) |
Deep | 127 (10.1) | 2 (7.7) |
